Drug Executive Collapses During Oval Office Press Conference
A press conference in the Oval Office was abruptly interrupted when a drug executive fainted while President Donald Trump announced a new deal aimed at lowering the cost of obesity drugs.
Incident Details
The event took place during a joint announcement involving President Trump and drugmakers, including Eli Lilly and Novo Nordisk, about expanding coverage and reducing prices for obesity treatments Zepbound and Wegovy.
David Ricks, CEO of Eli Lilly, noticed the executive's distress and asked,
“Are you okay? Gordon, are you okay?”
Response to the Collapse
The man who collapsed was identified as Gordon Findlay, global brand director for Novo Nordisk. Dr. Mehmet Oz immediately assisted as Findlay fell to his knees and lost consciousness.
Health and Human Services Secretary was also present during the incident. The press was quickly escorted out and the conference was paused.
Aftermath
Approximately 30 minutes later, the press conference resumed, and President Trump provided an update on the condition of the executive.
President Trump looks on as Administrator for the Centers for Medicare & Medicaid Services Dr. Mehmet Oz and others help Gordon Findlay of Novo Nordisk following his collapse.
Summary: During a press conference on drug price reductions, a Novo Nordisk executive unexpectedly collapsed, prompting immediate medical assistance and a brief interruption of the event.